UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation

The Journal of pharmacology and experimental therapeutics, 2008-12, Vol.327 (3), p.620

2008

Volltextzugriff (PDF)

The P2X3 antagonist P1, P5-di[inosine-5'] pentaphosphate binds to the desensitized state of the receptor in rat dorsal root ganglion neurons

The Journal of pharmacology and experimental therapeutics, 2005-10, Vol.315 (1), p.405

2005

Volltextzugriff (PDF)

Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain

Journal of medicinal chemistry, 2019-01, Vol.62 (2), p.831-856

2019

Volltextzugriff (PDF)

Correction to Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain

Journal of medicinal chemistry, 2019-02, Vol.62 (4), p.2213-2213

2019

Volltextzugriff (PDF)

Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain

Journal of medicinal chemistry, 2017-03, Vol.60 (6), p.2513-2525

2017

Volltextzugriff (PDF)

Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors

Bioorganic & medicinal chemistry letters, 2018-03, Vol.28 (5), p.958-962

2018

Volltextzugriff (PDF)

Discovery of new indole-based acylsulfonamide Nav1.7 inhibitors

Bioorganic & medicinal chemistry letters, 2019-02, Vol.29 (4), p.659-663

2019

Volltextzugriff (PDF)

Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box

Bioorganic & medicinal chemistry letters, 2016-09, Vol.26 (17), p.4165-4169

2016

Volltextzugriff (PDF)

Correction to Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na V 1.7 Inhibitors for the Treatment of Pain

Journal of medicinal chemistry, 2019-02, Vol.62 (4), p.2213-2213

2019

Volltextzugriff (PDF)

Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na V 1.7 Inhibitors for the Treatment of Pain

Journal of medicinal chemistry, 2019-01, Vol.62 (2), p.831-856

2019

Volltextzugriff (PDF)

Design and Synthesis of a New Series of 4‑Heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure–Activity Relationship

Journal of medicinal chemistry, 2016-12, Vol.59 (24), p.11171-11181

2016

Volltextzugriff (PDF)

Discovery of non-zwitterionic aryl sulfonamides as Nav1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation

Bioorganic & medicinal chemistry, 2017-10, Vol.25 (20), p.5490-5505

2017

Volltextzugriff (PDF)

Discovery of morpholine-based aryl sulfonamides as Na v 1.7 inhibitors

Bioorganic & medicinal chemistry letters, 2018-03, Vol.28 (5), p.958-962

2018

Volltextzugriff (PDF)

Development of New Benzenesulfonamides As Potent and Selective Na v 1.7 Inhibitors for the Treatment of Pain

Journal of medicinal chemistry, 2017-03, Vol.60 (6), p.2513-2525

2017

Volltextzugriff (PDF)

Development of 1H‑Pyrazolo[3,4‑b]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators

ACS medicinal chemistry letters, 2016-12, Vol.7 (12), p.1082-1086

2016

Volltextzugriff (PDF)

Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5

ACS medicinal chemistry letters, 2016-03, Vol.7 (3), p.289-293

2016

Volltextzugriff (PDF)

Discovery of new indole-based acylsulfonamide Na v 1.7 inhibitors

Bioorganic & medicinal chemistry letters, 2019-02, Vol.29 (4), p.659

2019

Volltextzugriff (PDF)

Development of 1 H -Pyrazolo[3,4- b ]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators

ACS medicinal chemistry letters, 2016-12, Vol.7 (12), p.1082-1086

2016

Volltextzugriff (PDF)

Discovery of non-zwitterionic aryl sulfonamides as Na v 1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation

Bioorganic & medicinal chemistry, 2017-10, Vol.25 (20), p.5490

2017

Volltextzugriff (PDF)

Evaluation and optimization of compound solubilization and delivery methods in a two-tiered ion channel lead optimization triage

Assay and drug development technologies, 2012-04, Vol.10 (2), p.202

2012

Volltextzugriff (PDF)

Revising IRS Publications: A Case Study

Technical communication (Washington), 1989-11, Vol.36 (4), p.332-340

1989

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Humans
(8)
Animals
(6)
Structure-Activity Relationship
(5)
Dose-Response Relationship, Drug
(4)
Life Sciences & Biomedicine
(4)
Mice
(4)
Pharmacology & Pharmacy
(4)
Science & Technology
(4)
Sulfonamides - Chemistry
(4)
Sulfonamides - Pharmacology
(4)
1.7 Inhibitor
(3)
Chemistry, Medicinal
(3)
Drug Discovery
(3)
Hek293 Cells
(3)
Mglur5
(3)
Molecular Structure
(3)
Nav1.7 Inhibitor
(3)
Nav1.7 Voltage-Gated Sodium Channel - Metabolism
(3)
Positive Allosteric Modulator
(3)
Rats
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation

The P2X3 antagonist P1, P5-di[inosine-5'] pentaphosphate binds to the desensitized state of the receptor in rat dorsal root ganglion neurons

Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain

Correction to Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain

Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain

Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors

Discovery of new indole-based acylsulfonamide Nav1.7 inhibitors

Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box

Correction to Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na V 1.7 Inhibitors for the Treatment of Pain

Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na V 1.7 Inhibitors for the Treatment of Pain

Design and Synthesis of a New Series of 4‑Heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure–Activity Relationship

Discovery of non-zwitterionic aryl sulfonamides as Nav1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation

Discovery of morpholine-based aryl sulfonamides as Na v 1.7 inhibitors

Development of New Benzenesulfonamides As Potent and Selective Na v 1.7 Inhibitors for the Treatment of Pain

Development of 1H‑Pyrazolo[3,4‑b]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators

Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5

Discovery of new indole-based acylsulfonamide Na v 1.7 inhibitors

Development of 1 H -Pyrazolo[3,4- b ]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators

Discovery of non-zwitterionic aryl sulfonamides as Na v 1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation

Evaluation and optimization of compound solubilization and delivery methods in a two-tiered ion channel lead optimization triage

Revising IRS Publications: A Case Study

Suchergebnisse filtern